Metabolic signature of obesity-associated insulin resistance and.pdf (1.38 MB)
0/0

Metabolic signature of obesity-associated insulin resistance and type 2 diabetes.

Download (1.38 MB)
journal contribution
posted on 22.11.2019 by Haya Al-Sulaiti, Ilhame Diboun, Maha V. Agha, Fatima FS Mohamed, Stephen Atkin, Alex S. Dömling, Mohamed A. Elrayess, Nayef A. Mazloum

BACKGROUND: Obesity is associated with an increased risk of insulin resistance and type 2 diabetes mellitus (T2DM). However, some obese individuals maintain their insulin sensitivity and exhibit a lower risk of associated comorbidities. The underlying metabolic pathways differentiating obese insulin sensitive (OIS) and obese insulin resistant (OIR) individuals remain unclear.

METHODS: In this study, 107 subjects underwent untargeted metabolomics of serum samples using the Metabolon platform. Thirty-two subjects were lean controls whilst 75 subjects were obese including 20 OIS, 41 OIR, and 14 T2DM individuals.

RESULTS: Our results showed that phospholipid metabolites including choline, glycerophosphoethanolamine and glycerophosphorylcholine were significantly altered from OIS when compared with OIR and T2DM individuals. Furthermore, our data confirmed changes in metabolic markers of liver disease, vascular disease and T2DM, such as 3-hydroxymyristate, dimethylarginine and 1,5-anhydroglucitol, respectively.

CONCLUSION: This pilot data has identified phospholipid metabolites as potential novel biomarkers of obesity-associated insulin sensitivity and confirmed the association of known metabolites with increased risk of obesity-associated insulin resistance, with possible diagnostic and therapeutic applications. Further studies are warranted to confirm these associations in prospective cohorts and to investigate their functionality.

Funding

Qatar National Research Fund (QNRF; Grant No. NPRP8-059-1-009). Biomedical Research Program funds of Weill Cornell Medicine—Qatar, a program funded by the Qatar Foundation for funding this project.

History

Comments

The original article is available at biomedcentral.com

Published Citation

Al-Sulaiti H, Diboun I, Agha MV, Mohamed FFS, Atkin S, Dömling AS, Elrayess MA, Mazloum NA. Metabolic signature of obesity-associated insulin resistance and type 2 diabetes. Journal of Translational Medicine. 2019;17(1):348.

Publication Date

22/10/2019

Publisher

BioMed Central

PubMed ID

31640727

Licence

Exports

Logo branding

Categories

Licence

Exports